灯盏花乙素通过靶向Hsp90aa1-MAPK通路抑制凋亡保护青光眼视网膜神经节细胞
本研究探讨灯盏花乙素(Scu)在青光眼中的神经保护作用及机制。体外采用谷氨酸诱导的视网膜兴奋性毒性青光眼模型,通过CCK-8、Hoechst 33342/碘化丙啶染色评估细胞活力,闪光视觉诱发电位、免疫荧光和苏木精-伊红染色评估RGC损伤与视功能,网络药理学和分子对接识别靶点,细胞热位移实验评估结合亲和力,siRNA沉默关键基因,Western blotting分析蛋白水平。结果发现Scu显著减轻损伤,Hsp90AA1为关键靶点,KEGG分析将保护作用与MAPK通路关联,GO分析强调凋亡调控作用,Hsp90aa1敲低可消除Scu的保护作用。结论:Scu通过靶向Hsp90aa1-MAPK通路抑制凋亡发挥神经保护作用,为青光眼治疗提供潜在策略。
要点
- Scu在谷氨酸诱导的视网膜兴奋性毒性青光眼模型中显著减轻损伤。
- 网络药理学和分子对接确定Hsp90AA1为Scu的关键靶点。
- Hsp90aa1敲低可消除Scu的保护作用,证实其通过Hsp90aa1-MAPK通路抑制凋亡。
核心结论
- Scu通过靶向Hsp90aa1-MAPK通路抑制凋亡,在青光眼中发挥神经保护作用,为青光眼管理提供潜在治疗策略。
研究设计与样本
- 研究采用谷氨酸诱导的视网膜兴奋性毒性青光眼模型,通过CCK-8和Hoechst 33342/碘化丙啶染色评估细胞活力,闪光视觉诱发电位、免疫荧光和苏木精-伊红染色评估RGC损伤与视功能,网络药理学和分子对接识别靶点,细胞热位移实验评估结合亲和力,siRNA沉默关键基因,Western blotting分析蛋白水平。
主要发现
- Scu显著减轻谷氨酸诱导的视网膜兴奋性毒性青光眼模型中的损伤。
- 网络药理学和分子对接确定Hsp90AA1为关键靶点。
- KEGG分析将Scu的保护作用与MAPK通路关联,GO分析强调其在凋亡调控中的作用。
- Scu通过调节Hsp90aa1-MAPK通路减轻凋亡,Hsp90aa1敲低可消除Scu的保护作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glaucoma, a major cause of irreversible blindness, is characterized by progressive retinal ganglion cells (RGCs) degeneration. Existing treatments can merely delay disease progression, failing to prevent RGC loss or visual field defects. For the management of ophthalmic diseases, Scutellarin (Scu) has demonstrated neuroprotective potential, but its efficacy and mechanisms in glaucoma remain unexplored. This study aims to evaluate the neuroprotective role of Scu in glaucoma and to reveal its underlying mechanisms. METHODS: Cell viability was assessed using CCK-8 and Hoechst 33342/propidium iodide staining. RGC damage and visual function were evaluated via flash visual evoked potential, immunofluorescence and hematoxylin-eosin staining. The potential targets and pathways were identified by network pharmacology, whereas the Scu-target binding affinity was evaluated by molecular docking and cellular thermal shift assay. Expression of key genes was silenced using siRNA, and protein levels were analyzed by Western blotting. RESULTS: Scu significantly mitigated the damage in a glutamate-induced retinal excitotoxicity glaucoma model. Network pharmacology and molecular docking identified Hsp90AA1 as a key target. Kyoto Encyclopedia of Genes and Genomes analysis associated the protective effects of Scu with the MAPK pathway, which was further supported by GO analysis that highlights its role in apoptosis regulation. Overall, Scu was found to mitigate apoptosis by modulating the Hsp90aa1-MAPK pathway, evidenced by the fact that Hsp90aa1 knockdown abolished the protective effects of Scu. CONCLUSIONS: Scu exerts neuroprotective effects in glaucoma by targeting the Hsp90aa1-MAPK pathway, thereby suppressing apoptosis. This offers a potential therapeutic strategy for glaucoma management.
引用
- Su JZ, Wang J, Gao ZL, et al. Scutellarin Protects Retinal Ganglion Cells in Glaucoma by Targeting the Hsp90aa1-MAPK Pathway to Inhibit Apoptosis. Invest Ophthalmol Vis Sci. 2025. PMID: 41251525. doi:10.1167/iovs.66.14.44
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。